Trademark Overview
On Wednesday, February 18, 2026, a trademark application was filed for MENDRA with the United States Patent and Trademark Office. The USPTO has given the MENDRA trademark a serial number of 99658639. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 18, 2026. This trademark is owned by Mendra, Inc.. The MENDRA trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
downloadable artificial intelligence software for use with rare diseases; downloadable artificial intelligence software for use in the field of medicine and medical research; downloadable artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; downloadable software platforms for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; downloadable software for identifying and recruiting clinical trial participants; downloadable software for managing global regulatory submissions and market access data; downloadable software for mapping and forecasting rare disease populations; downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; d...
Pharmaceutical preparations and substances; therapeutic and prophylactic pharmaceutical products; medicines for the treatment and prevention of rare diseases, autoimmune diseases, inflammatory diseases, and infectious diseases and disorders; pharmaceutical products for use in medical research and clinical development; pharmaceutical products in development for regulatory approval
Scientific research and development services in the fields of pharmaceuticals, therapeutics, and medicine; research and development of pharmaceutical products, therapies, and treatments; biomedical research services; pharmaceutical research and clinical development services; providing online non-downloadable software artificial intelligence software for use with rare diseases; providing online non-downloadable software artificial intelligence software for use in the field of medicine and medical research; providing online non-downloadable software artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; providing online non-downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; providing online non-downloadable software for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including so...
Medical research and development services; providing medical and scientific information in the field of rare diseases; providing health and medical information relating to diseases, disorders, diagnosis, treatment, and prevention; medical advisory services relating to pharmaceutical research and development; Consulting services in the field of rare disease drug development; Prevention, diagnostics, treatment, and therapy for rare diseases